News
Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for the KwikPen® format of its rival therapy Mounjaro (tirzepatide) ...
The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant ...
After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...
We view a Medifast revitalization as hinging on a steep coach network inflection. Read why we think MED stock becomes a core ...
3h
BBC Good Food on MSNWe asked 7 experts what they really think of weight loss jabsBy Vicky ChandlerOpinions on the new breed of slimming drugs, like Ozempic and Mounjaro, are strong and varied. But what about those who are really in the know?Within the last year we’ve seen a huge ...
Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...
The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...
Despite losing out to Irish-owned Applegreen, Waltham-based Global Partners says its bid would’ve brought in more revenue and ...
FOX News on MSN13h
New weight loss medicine seen as an alternative to Ozempic, GLP-1 drugsOne of the largest theater chains in the US again files for bankruptcy Officials provide update on California fireworks ...
A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
J une Jo Lee grew up at the intersection of Korea, California, and Texas. At an early age, she tried to understand why her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results